Interactions of flurochemicals with rat liver fatty acid-binding protein

被引:333
作者
Luebker, DJ
Hansen, KJ
Bass, NM
Butenhoff, JL
Seacat, AM
机构
[1] 3M Co, Dept Med, Corp Toxicol, St Paul, MN 55144 USA
[2] 3M Co, Environment Technol Serv, St Paul, MN 55144 USA
[3] 3M Co, Safety Serv, St Paul, MN 55144 USA
[4] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA
关键词
liver fatty acid-binding protein; perfluorooctanesulfonate; perfluorooctanoate; N-ethylperfluorooctanesulfonamide; N-ethylperfluorooctanesulfonamido ethanol; relative dissociation constants;
D O I
10.1016/S0300-483X(02)00081-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Liver-fatty acid binding protein (L-FABP) is an abundant intracellular lipid-carrier protein. The hypothesis that perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and certain related perfluorooctanesulfonamide-based fluorochemicals (PFOSAs) can interfere with the binding affinity of L-FABP for fatty acids was tested. The relative effectiveness of PFOA, PFOS, N-ethylperfluorooctanesulfonamide (N-EtFOSA), N-ethylperfluorooctanesulfonamido ethanol (N-EtFOSE), and of the strong peroxisome proliferator Wyeth-14643 (WY) to inhibit 11-(5-dimethylaminonapthalenesulphonyl)-undecanoic acid (DAUDA) binding to-L-FABP was determined. The dissociation constant (Kd) of the DAUDA-L-FABP complex was 0.47 nM. PFOS exhibited the highest level of inhibition of DAUDA-L-FABP binding in the competitive binding assays, followed by N-EtFOSA, WY, and, with equal IC(50)s, N-EtFOSE and PFOA. The in vitro data presented in this study support the hypothesis that these fluorochemicals may interfere with the binding of fatty acids or other endogenous ligands to L-FABP. Furthermore, this work provides evidence to support the hypothesis that displacement of endogenous ligands from L-FABP may contribute to toxicity in rodents fed these fluorochemicals. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:175 / 185
页数:11
相关论文
共 40 条
[1]   POSSIBLE INVOLVEMENT OF FATTY-ACID BINDING-PROTEIN IN PEROXISOMAL BETA-OXIDATION OF FATTY-ACIDS [J].
APPELKVIST, EL ;
DALLNER, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1980, 617 (01) :156-160
[2]  
Banks R.E., 1994, ORGANOFLUORINE CHEM
[3]  
BASS MM, 1993, HEPATIC TRANSPORT BI, P421
[4]   ALKYLTHIOACETIC ACID (3-THIA FATTY-ACIDS) - A NEW GROUP OF NON-BETA-OXIDIZABLE, PEROXISOME-INDUCING FATTY-ACID ANALOGS .1. A STUDY ON THE STRUCTURAL REQUIREMENTS FOR PROLIFERATION OF PEROXISOMES AND MITOCHONDRIA IN RAT-LIVER [J].
BERGE, RK ;
AARSLAND, A ;
KRYVI, H ;
BREMER, J ;
AARSAETHER, N .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 1004 (03) :345-356
[5]   EFFECTS OF AMMONIUM PERFLUOROOCTANOATE ON LEYDIG-CELL FUNCTION - IN-VITRO, IN-VIVO, AND EX-VIVO STUDIES [J].
BIEGEL, LB ;
LIU, RCM ;
HURTT, ME ;
COOK, JC .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 134 (01) :18-25
[6]   INDUCTION OF FATTY-ACID BINDING-PROTEIN BY PEROXISOME PROLIFERATORS IN PRIMARY HEPATOCYTE CULTURES AND ITS RELATIONSHIP TO THE INDUCTION OF PEROXISOMAL BETA-OXIDATION [J].
BRANDES, R ;
KAIKAUS, RM ;
LYSENKO, N ;
OCKNER, RK ;
BASS, NM .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1034 (01) :53-61
[7]  
BUTENHOFF JL, 2001, COMP SUBCHRONIC TOXI, V60
[8]   INTERACTION OF LY171883 AND OTHER PEROXISOME PROLIFERATORS WITH FATTY-ACID-BINDING PROTEIN ISOLATED FROM RAT-LIVER [J].
CANNON, JR ;
EACHO, PI .
BIOCHEMICAL JOURNAL, 1991, 280 :387-391
[9]   Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? [J].
Cattley, RC ;
DeLuca, J ;
Elcombe, C ;
Fenner-Crisp, P ;
Lake, BG ;
Marsman, DS ;
Pastoor, TA ;
Popp, JA ;
Robinson, DE ;
Schwetz, B ;
Tugwood, J ;
Wahli, W .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1998, 27 (01) :47-60
[10]   Peroxisome proliferator-activated receptors: Nuclear control of metabolism [J].
Desvergne, B ;
Wahli, W .
ENDOCRINE REVIEWS, 1999, 20 (05) :649-688